Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis
- 11 October 2010
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 30 (4) , 389-397
Abstract
Tumor progression locus 2 (Tpl2) is a serine/threonine kinase in the mitogen-activated protein kinase signal transduction cascade known to regulate inflammatory pathways. Previously identified as an oncogene, its mutation or overexpression is reported in a variety of human cancers. To address its role in skin carcinogenesis, Tpl2−/− or wild-type (WT) C57BL/6 mice were subjected to a two-stage dimethylbenzanthracene/12-O-tetradecanoylphorbol-13-acetate (TPA) mouse skin carcinogenesis model. Tpl2−/− mice developed a significantly higher incidence of tumors (80%) than WT mice (17%), as well as a reduced tumor latency and a significantly higher number of total tumors (113 vs 6). Moreover, Tpl2−/− mice treated with TPA experienced significantly higher nuclear factor kappaB (NF-κB) activation, edema, infiltrating neutrophils and production of proinflammatory cytokines than did WT mice. We investigated the role of the p38, JNK, MEK and NF-κB signaling pathways both in vitro and in vivo in WT and Tpl2−/− mice by using inhibitors for each of these pathways. We confirmed that the proinflammatory effect in Tpl2−/− mice was due to heightened activity of the NF-κB pathway. These studies indicate that Tpl2 may serve more as a tumor suppressor than as an oncogene in chemically induced skin carcinogenesis, with its absence contributing to both tumorigenesis and inflammation.Keywords
This publication has 45 references indexed in Scilit:
- IL-12 deficiency suppresses 12- O -tetradecanoylphorbol-13-acetate-induced skin tumor development in 7,12-dimethylbenz( a )anthracene-initiated mouse skin through inhibition of inflammationCarcinogenesis, 2009
- Tpl2 kinase regulates T cell interferon-γ production and host resistance to Toxoplasma gondii Journal of Experimental Medicine, 2008
- Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cellsProceedings of the National Academy of Sciences, 2008
- The Two-Faced NF-κB in the SkinInternational Reviews of Immunology, 2008
- Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesisCancer Science, 2007
- Tumor Progression Locus-2 Is a Critical Regulator of Pancreatic and Lung Inflammation during Acute PancreatitisJournal of Biological Chemistry, 2007
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Inflammation in epithelial skin tumours: Old stories and new ideasEuropean Journal of Cancer, 2006
- Inflammation and cancerNature, 2002
- Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-κBOncogene, 1998